ID 1477 -
Laktoferyna bydlęca
PL: Laktoferyna bydlęca
EN: Bovine lactoferrin
Pdf: various food(s)/food constituent(s)
1.39. Obrona immunologiczna przed patogenami (ID 1477)
The claimed effect is ―antimicrobial/antiviral/innate host defense‖. The Panel assumes that the target population is the general population.
In the context of the clarifications provided by Member States, the Panel assumes that the claimed effect refers to immune defence against pathogens.
The Panel notes that the type of infection has not been specified and the references provided addressed several effects (e.g. related to treatment of tinea pedis (athletes foot), eradication of Helicobacter pylori, lower respiratory tract illnesses, the effects of long-term administration of bovine lactoferrin in patients with chronic hepatitis C, effects in post-surgical patients) and it was not possible to establish which of these effects is the target for the claim.
The Panel considers that the claimed effect is general and non-specific, and does not refer to any specific health claim as required by Regulation (EC) No 1924/2006.
Warunki i możliwe ograniczenia stosowania oświadczenia
200 mg bLF per day
colostrum from non-hyperimmunised cows
